Differentiating multiple sclerosis from AQP4-neuromyelitis optica spectrum disorder and MOG-antibody disease with imaging.
26 Oct, 2022 | 14:24h | UTC
Commentary on Twitter
Published online: Cortese @RosaCortese5 and colleagues assessed whether imaging characteristics typical of multiple sclerosis (#MS) discriminate relapsing remitting MS from AQP4-NMOSD and #MOGAD, alone and in combination. Learn more: https://t.co/AWYoEZQDP9 #NeuroTwitter pic.twitter.com/3Pytn45uLx
— Neurology Journal (@GreenJournal) October 12, 2022